TG Therapeutics (NASDAQ:TGTX) Shareholders Have Earned a 36% CAGR Over the Last Five Years
10 Health Care Stocks With Whale Alerts In Today's Session
TG Therapeutics Inc (TGTX): Short Seller Sentiment Is Bearish
Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock?
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $49
H.C. Wainwright analyst Edward White maintains $TG Therapeutics(TGTX.US)$ with a buy rating, and maintains the target price at $49.According to TipRanks data, the analyst has a success rate of 32.9%
Analysts' Top Healthcare Picks: TG Therapeutics (TGTX), Boston Scientific (BSX)